Article
DNMT3A mutations in acute myeloid leukemia.
The New England journal of medicine - 16 Dec 2010
Ley Timothy J, Ding Li, Walter Matthew J, McLellan Michael D, Lamprecht Tamara, Larson David E, Kandoth Cyriac, Payton Jacqueline E, Baty Jack, Welch John, Harris Christopher C, Lichti Cheryl F, Townsend R Reid, Fulton Robert S, Dooling David J, Koboldt Daniel C, Schmidt Heather, Zhang Qunyuan, Osborne John R, Lin Ling, O'Laughlin Michelle, McMichael Joshua F, Delehaunty Kim D, McGrath Sean D, Fulton Lucinda A, Magrini Vincent J, Vickery Tammi L, Hundal Jasreet, Cook Lisa L, Conyers Joshua J, Swift Gary W, Reed Jerry P, Alldredge Patricia A, Wylie Todd, Walker Jason, Kalicki Joelle, Watson Mark A, Heath Sharon, Shannon William D, Varghese Nobish, Nagarajan Rakesh, Westervelt Peter, Tomasson Michael H, Link Daniel C, Graubert Timothy A, DiPersio John F, Mardis Elaine R, Wilson Richard K
Abstract excerpt
BACKGROUND: The genetic alterations responsible for an adverse outcome in most patients with acute myeloid leukemia (AML) are unknown. METHODS: Using massively parallel DNA sequencing, we identified a somatic mutation in DNMT3A, encoding a DNA methyltransferase, in the genome of cells from a pati...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
